Sweroside

CAS No. 14215-86-2

Sweroside( —— )

Catalog No. M18009 CAS No. 14215-86-2

Sweroside is a promising osteoporosis therapeutic natural product, has anti-osteoporotic effect on the human MG-63 cells and rat osteoblasts.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
2MG 29 In Stock
5MG 48 In Stock
10MG 67 In Stock
25MG 107 In Stock
50MG 152 In Stock
100MG 222 In Stock
200MG 331 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sweroside
  • Note
    Research use only, not for human use.
  • Brief Description
    Sweroside is a promising osteoporosis therapeutic natural product, has anti-osteoporotic effect on the human MG-63 cells and rat osteoblasts.
  • Description
    Sweroside possesses strong hepatoprotective effect. Sweroside is a promising osteoporosis therapeutic natural product, has anti-osteoporotic effect on the human MG-63 cells and rat osteoblasts.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    14215-86-2
  • Formula Weight
    358.34
  • Molecular Formula
    C16H22O9
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (279.06 mM)
  • SMILES
    C=CC1C2CCOC(=O)C2=COC1OC3C(C(C(C(O3)CO)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pyridone 6

    Pyridone 6(CMP 6) is a potent and selective inhibitor of JAK1 (IC50=15 nM, murine JAK1), JAK2 (IC50=1 nM), JAK3 (Ki=5 nM), and Tyk2 (IC50=1 nM).

  • NVP-BSK805

    A potent, selective and ATP-competitive inhibitor of JAK2(V617F) and wt JAK2 (IC50=0.5 nM).

  • S-Ruxolitinib

    Ruxolitinib (INCB018424) is the first potent selective JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays.